MedTrace Logo

Comparing the PiCCO Monitor to the Non-invasive Biobeat (BB)-316PW in ICU Patients

NCT04215627 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2021-07-07

No results posted yet for this study

Summary

The aim of this study is to compare hemodynamic monitoring using the invasive PiCCO device to the BB-613PW wireless, non-invasive PPG-based device, in critically ill patients within the ICU, suffering from hemodynamic instability and in need of vasopressor support. Data will be gathered prospectively and analysed retrospectively.

Conditions

  • Critically Ill
  • Hemodynamic Instability

Interventions

DEVICE

non-invasive monitoring

Comparing the PiCCO monitor to the non-invasive BB-613PW device in hemodynamically unstable critically ill patients in the ICU

Sponsors & Collaborators

  • Assaf-Harofeh Medical Center

    collaborator OTHER_GOV

  • Biobeat Technologies Ltd.

    lead INDUSTRY

Principal Investigators

  • Ayana Dvir, MD, MHA · The Assaf Harofeh Medical Center, Tzrifin, Israel

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-26
Primary Completion
2021-04-15
Completion
2021-04-30
FDA Device
Yes

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04215627 on ClinicalTrials.gov